SCHEMBL9477367

SCHEMBL9477367

O=c1[nH]cnc2c1nnn2Cc1c(F)cccc1F

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA2B P29275 1/20 0.46
ADORA1 P30542 1/20 0.46
TSHR P16473 6/20 0.45
HPGD P15428 4/20 0.45
PARP1 P09874 2/20 0.44
ALDH1A1 P00352 5/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
LMNA P02545 4/20 0.43
KDM4E B2RXH2 2/20 0.43
GAA P10253 2/20 0.43
GPR55 Q9Y2T6 1/20 0.43
HSD17B10 Q99714 1/20 0.43
MAPT P10636 2/20 0.41
USP2 O75604 1/20 0.41
ALOX15 P16050 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9475856 0.80 HPGD (0.59) TSHRHPGDALDH1A1KMT2AMEN1
SCHEMBL9476195 0.76 ADORA3 (0.51) ADORA3ADORA2AADORA2BADORA1TSHR
SCHEMBL9476371 0.75 LMNA (0.53) ADORA3ADORA2AADORA2BADORA1TSHR
SCHEMBL9476477 0.75 MEN1 (0.62) TSHRHPGDALDH1A1KMT2AMEN1
SCHEMBL21127684 0.74 HPRT1 (0.40) PARP1ALDH1A1KMT2AMEN1LMNA
SCHEMBL20224894 0.74 ADORA2A (0.46) ADORA3ADORA2AADORA2BADORA1HPGD
SCHEMBL9476832 0.73 HSD17B10 (0.57) ADORA3ADORA2AADORA2BADORA1TSHR
SCHEMBL30931879 0.72 PDE8B (0.53) ADORA3TSHRHPGDALDH1A1KMT2A
SCHEMBL14094136 0.71 POLB (0.43) TSHRHPGDALDH1A1KMT2AMEN1
SCHEMBL23922180 0.71 KDM4A (0.38) ADORA2AALDH1A1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5204353-A 3-benzyl-3H-1,2,3-triazolo[4,5-d]pyrimidines, compositions thereof, and method of treating epilepsy therewith CIBA-GEIGY CORPORATION (US) 1993-04-20 US disclosed
EP-0288431-B1 3H-1,2,3-triazolo[4,5-d]pyrimidines CIBA-GEIGY AG (CH) 1992-08-19 EP disclosed
EP-0288431-A1 3H-1,2,3-triazolo[4,5-d]pyrimidines CIBA-GEIGY AG (CH) 1988-10-26 EP disclosed